Chicago Partners Investment Group’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
Chicago Partners Investment Group's RMD Position: Q2 2026 in Review
Chicago Partners Investment Group increased its ResMed (RMD) stake by 11% in Q2 2026, buying an estimated $57.4K and bringing the position to 2,890 shares worth $555K. The position accounts for 0.01% of the portfolio, ranked #933.
Chicago Partners Investment Group first reported a position in RMD in Q4 2024 and has held it in 7 quarters since. The position peaked at $580K in Q1 2026. 882 funds tracked by Wall St. Rank hold RMD as of Q2 2026.
- Chicago Partners Investment Group held 2,890 shares of ResMed worth $555K as of Q2 2026.
- Chicago Partners Investment Group bought 277 ResMed shares in Q2 2026, an estimated $57.4K.
- ResMed made up 0.01% of Chicago Partners Investment Group's portfolio in Q2 2026, its #933 holding.
- Chicago Partners Investment Group first reported a position in ResMed in Q4 2024 and has held it in 7 quarters since.
- Chicago Partners Investment Group's ResMed position peaked at $580K in Q1 2026.
- 882 funds tracked by Wall St. Rank held ResMed as of Q2 2026.
Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.